Search Results - "Ohtani, Mikinobu"

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer by Koie, Takuya, Ohyama, Chikara, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Yoneyama, Tohru, Tobisawa, Yuki, Yamauchi, Atsushi, Shimazui, Toru, Ohtani, Mikinobu

“…The aim of this study was to compare 29 muscle-invasive bladder cancer patients who received neoadjuvant chemotherapy (NAC) followed by immediate…”
Get full text

Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study by Kandori, Shuya, Yoshino, Takayuki, Tsutsumi, Masakazu, Yamauchi, Atsushi, Ohtani, Mikinobu, Fukuhara, Yoshiharu, Miyanaga, Naoto, Miyazaki, Jun, Nishiyama, Hiroyuki, Shimazui, Toru

“…We retrospectively analyzed castration-resistant prostate cancer (CRPC) patients treated with secondary hormonal therapies (SHTs) prior to docetaxel therapy…”
Get full text

The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study by Fujimoto, Kiyohide, Hirao, Yoshihiko, Ohashi, Yasuo, Shibata, Yasuhiro, Fuji, Kohzo, Tsuji, Hidenori, Miyazawa, Katsuhito, Ohtani, Mikinobu, Furuya, Ryoji, Boku, Eitetsu

“…Purpose. To evaluate the effects of chlormadinone acetate (CMA), progesterone-derived antiandrogen, on lower urinary tract symptoms (LUTS) and erectile…”
Get full text

Effects of a Soybean Isoflavone Mixture on Carcinogenesis in Prostate and Seminal Vesicles of F344 Rats by Onozawa, Mizuki, Kawamori, Toshihiko, Baba, Masaki, Fukuda, Kazunori, Toda, Toshiya, Sato, Hidetaka, Ohtani, Mikinobu, Akaza, Hideyuki, Sugimura, Takashi, Wakabayashi, Keiji

“…Several epidemiological studies have suggested an inverse association between the risk of prostate cancer and intake of soybeans and their products. In vitro…”
Get full text

Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection by Miyanaga, Naoto, Akaza, Hideyuki, Tsukamoto, Sadamu, Shimazui, Toru, Ohtani, Mikinobu, Ishikawa, Satoru, Noguchi, Ryosuke, Manabe, Fumio, Nishijima, Yukiko, Kikuchi, Koji, Sato, Ken, Hayashi, Hitoshi, Kondo, Fukuji, Shiraiwa, Hiroshi, Aoyama, Osamu

“…In a prospective study we compared the usefulness of urinary nuclear matrix protein 22 (NMP22) with that of urine cytology and other urinary markers in the…”
Get full text

Detection and Cloning of a Protein Recognized by Anti‐human Prostate‐specific Antigen (PSA) Antibody in the Rat Ventral Prostate by Onozawa, Mizuki, Fukuda, Kazunori, Watanabe, Masahiko, Ohtani, Mikinobu, Akaza, Hideyuki, Sugimura, Takashi, Wakabayashi, Keiji

“…Prostate‐specific antigen (PSA), a 33 kDa glycoprotein produced in the epithelium of the human prostate, has become established as a useful tumor marker for…”
Get full text

Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study by Fujimoto, Kiyohide, Hirao, Yoshihiko, Ohashi, Yasuo, Shibata, Yasuhiro, Fuji, Kohzo, Tsuji, Hidenori, Shimizu, Nobutaka, Miyazawa, Katsuhito, Nagata, Masao, Ohtani, Nikinobu, Furuya, Ryoji, Boku, Eitetsu

“…In this prospective multicenter study, we investigated the changes in serum prostate-specific antigen (PSA) and testosterone levels after treatment with…”
Get full text

Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria by Miyanaga, Naoto, Akaza, Hideyuki, Tsukamoto, Taiji, Ishikawa, Satoru, Noguchi, Ryosuke, Ohtani, Mikinobu, Kawabe, Kazuki, Kubota, Yoshinobu, Fujita, Kimio, Obata, Koji, Hirao, Yoshihiko, Kotake, Toshihiko, Ohmori, Hiroyuki, Kumazawa, Joichi, Koiso, Kenkichi

“…Purpose: The aim of the present study was to determine the clinical usefulness of nuclear matrix protein 22 (NMP22) as a new urinary marker for the screening…”
Get full text

Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external‐beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open‐label, randomized, phase 3 trial by Ito, Kazuto, Kobayashi, Mikio, Komiyama, Motokiyo, Naito, Seiji, Nishimura, Kazuo, Yonese, Junji, Hashine, Katsuyoshi, Saito, Shiro, Arai, Gaku, Shinohara, Mitsuru, Masumori, Naoya, Shimizu, Nobuaki, Satoh, Takefumi, Yamauchi, Atsushi, Tochigi, Tatsuo, Takezawa, Yutaka, Fujimoto, Hiroyuki, Yokomizo, Akira, Kakimoto, Ken‐Ichi, Fukui, Iwao, Karasawa, Katsuyuki, Tsukamoto, Taiji, Nozaki, Miwako, Hasumi, Masaru, Ishiyama, Hiromichi, Ohtani, Mikinobu, Kuwahara, Masaaki, Harada, Masaoki, Ohashi, Yasuo, Kotake, Toshihiko, Kakizoe, Tadao, Suzuki, Kazuhiro, Yamanaka, Hidetoshi

“…Background To date, research has not determined the optimal procedure for adjuvant androgen deprivation therapy (ADT) in patients with locally advanced…”
Get full text

Immunological protection induced by bacillus Calmette-Guérin treatment in a murine bladder tumor model by Iwasaki, Akio, Kawai, Koji, Hayashi, Hitoshi, Ikeda, Noriko, Toida, Ichiro, Ohtani, Mikinobu, Akaza, Hideyuki

“…Background: It has been previously reported that MBT‐2 tumor growth is completely inhibited when mice are inoculated with bacillus Calmette–Guérin (BCG). In…”
Get full text

MP49-14 SYSTEMIC TRANSDUCTION OF P16 INK4A ANTITUMOR PEPTIDE INHIBITS LUNG METASTASIS OF MBT-2 BLADDER TUMOR CELL LINE IN MICE by Shimazui, Toru, Yoshikawa, Kazuhiro, Miyazaki, Jun, Uchida, Kazuhiko, Yamauchi, Atsushi, Ohtani, Mikinobu, Nishiyama, Hiroyuki

Get full text

MP49-14 SYSTEMIC TRANSDUCTION OF P16INK4A ANTITUMOR PEPTIDE INHIBITS LUNG METASTASIS OF MBT-2 BLADDER TUMOR CELL LINE IN MICE by Shimazui, Toru, Yoshikawa, Kazuhiro, Miyazaki, Jun, Uchida, Kazuhiko, Yamauchi, Atsushi, Ohtani, Mikinobu, Nishiyama, Hiroyuki

Get full text

Implementing quality indicators using health insurance claims data linked to the hospital-based cancer registry by Nakamura, Fumiaki, Masuda, Masato, Teramoto, Norihiro, Mizumoto, Kazuhiro, Mekata, Eiji, Higashide, Shunichi, Ohtani, Mikinobu, Higashi, Takahiro

“…Abstract only 94 Background: To establish systematic monitoring of cancer care quality, we measured the quality of cancer care in several facilities through…”
Get full text

Expression of antitumor response. Role of attachment and viability of bacillus Calmette-Guérin to bladder cancer cells by Akaza, H, Iwasaki, A, Ohtani, M, Ikeda, N, Niijima, K, Toida, I, Koiso, K

“…Antitumor effects of Bacillus Calmette-Guérin (BCG) against superficial urinary bladder cancer is known to be strong when BCG is directly infused into the…”
Get more information

A new tumor marker for bladder cancer by Koiso, K, Akaza, H, Ohtani, M, Miyanaga, N, Aoyagi, K

“…Biochemical assay and immunohistochemical staining of neutral endopeptidase were performed on bladder cancer cells. In superficial bladder cancer the enzyme…”
Get more information

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial by Yokomizo, Akira, Koga, Hirofumi, Ito, Kazuto, Takezawa, Yutaka, Komiyama, Motokiyo, Nishimura, Kazuo, Yonese, Junji, Hashine, Katsuyoshi, Masumori, Naoya, Arai, Gaku, Saito, Shiro, Shinohara, Mitsuru, Shimizu, Nobuaki, Yamauchi, Atsushi, Satoh, Takefumi, Tochigi, Tatsuo, Kobayashi, Mikio, Fujimoto, Hiroyuki, Kakimoto, Ken‐ichi, Fukui, Iwao, Tsukamoto, Taiji, Nozaki, Miwako, Karasawa, Katsuyuki, Hasumi, Masaru, Ohtani, Mikinobu, Ishiyama, Hiromichi, Kuwahara, Masaaki, Harada, Masaoki, Ohashi, Yasuo, Kotake, Toshihiko, Kakizoe, Tadao, Suzuki, Kazuhiro, Naito, Seiji, Yamanaka, Hidetoshi, Ohyama, Atsuko, Ohashi, Yasuo, Harada, Masaoki, Yamamoto, T, Miyakubo, M, Fujizuka, Y, Akimoto, T, Mitsuhashi, N, Ishikawa, H, Matsuoka, N, Sumi, M, Ito, Y, Hamano, T, Tabata, K, Tsumura, H, Iwamura, M, Komori, S, Hayakawa, K, Kitano, M

“…Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT)…”
Get full text

Urophonographic studies of benign prostatic hypertrophy by Koiso, K, Nemoto, R, Ohtani, M

“…The sonic detection and recording systems of urethral sounds generated during micturition were developed. This procedure was tentatively postulated as…”
Get more information

L-Isoleucine and L-Leucine: Tumor Promoters of Bladder Cancer in Rats by Nishio, Yasunori, Kakizoe, Tadao, Ohtani, Mikinobu, Sato, Shigeaki, Sugimura, Takashi, Fukushima, Shoji

“…A 4-week assay for screening tumor promoters of bladder cancer has been developed in which increased agglutinability of isolated rat bladder cells with…”
Get full text

Quality of gastric cancer care in designated cancer care hospitals in Japan by HIGASHI, Takahiro, NAKAMURA, Fumiaki, OHTANI, Mikinobu, YAMAGUCHI, Takashi, SUGIURA, Nobuyuki, HIGASHIDE, Shunichi, HAGA, Yoshio, KINOSHITA, Akitoshi, YAMAMOTO, Tetsuo, EZAKI, Takahiro, HANADA, Shuichi, MAKITA, Fujio, SHIMADA, Yasuhiro, SOBUE, Tomotaka, OKAMURA, Takeshi, SHINKAI, Tetsu, MURANAKA, Toru, KAMIIKE, Wataru, MEKATA, Eiji, KONDO, Ken, WADA, Yuichi, SAKAI, Hironori

“…To develop a set of process-of-care quality indicators (QIs) that would cover a wide range of gastric cancer care modalities and to examine the current state…”
Get full text

Quality of gastric cancer care in designated cancer care hospitalsin Japan by HIGASHI, TAKAHIRO, NAKAMURA, FUMIAKI, SHIMADA, YASUHIRO, SHINKAI, TETSU, MURANAKA, TORU, KAMIIKE, WATARU, MEKATA, EIJI, KONDO, KEN, WADA, YUICHI, SAKAI, HIRONORI, OHTANI, MIKINOBU, YAMAGUCHI, TAKASHI, SUGIURA, NOBUYUKI, HIGASHIDE, SHUNICHI, HAGA, YOSHIO, KINOSHITA, AKITOSHI, YAMAMOTO, TETSUO, EZAKI, TAKAHIRO, HANADA, SHUICHI, MAKITA, FUJIO, SOBUE, TOMOTAKA, OKAMURA, TAKESHI

“…Objective. To develop a set of process-of-care quality indicators (QIs) that would cover a wide range of gastric cancer care modalities and to examine the…”
Get full text